Roswell Park Comprehensive Cancer Center, Division of Cancer Prevention and Control, Elm & Carlton Streets, Buffalo, NY, 14203, USA.
Roswell Park Comprehensive Cancer Center, Division of Cancer Prevention and Control, Elm & Carlton Streets, Buffalo, NY, 14203, USA.
Cancer Epidemiol. 2019 Oct;62:101580. doi: 10.1016/j.canep.2019.101580. Epub 2019 Aug 7.
Update information on racial disparities in ovarian cancer survival from the Surveillance, Epidemiology, and End Results (SEER) Program.
Data on women with epithelial ovarian cancer from the SEER Program between 1995-2015 were collected including; patient ID, age at diagnosis, year of diagnosis, surgery, chemotherapy, radiation, insurance status, region of registry, tumor grade, tumor histology, tumor summary stage, survival months, race/ethnicity, and vital status. Multivariable analyses were performed to examine overall survival, differences in survival by age at diagnosis, by year of diagnosis, risk of not receiving surgery, and risk of 12-month death across racial/ethnic groups.
Non-Hispanic black women (n = 4261) had an increased risk of overall mortality (HR = 1.28, CI: 1.23-1.33) when compared to non-Hispanic white women (n = 47,475), which appears more pronounced among women diagnosed under age 50. Hispanic women (n = 7052) had no difference in survival when compared to non-Hispanic white women (HR = 1.03, CI: 0.99-1.07). Non-Hispanic Asian/PI women (n = 5008) exhibited slightly reduced risk (HR = 0.95, CI: 0.91-0.99) when compared to non-Hispanic white women. Risk of not receiving surgical intervention remains high among non-Hispanic black women and Hispanic women, when compared to non-Hispanic white women. Non-Hispanic black women, non-Hispanic Asian/PI women, and Hispanic women were all at significantly greater risk of dying within the first 12 months of cancer diagnosis when compared to non-Hispanic white women.
Disparities in survival remain across various racial/ethnic groups, when compared to non-Hispanic white women with ovarian cancer. These disparities should continue to be examined in an effort to decrease such gaps.
更新监测、流行病学和最终结果(SEER)计划中卵巢癌生存种族差异的信息。
收集了 1995 年至 2015 年间 SEER 计划中患有上皮性卵巢癌的女性患者的数据,包括:患者 ID、诊断时年龄、诊断年份、手术、化疗、放疗、保险状况、登记区域、肿瘤分级、肿瘤组织学、肿瘤总结分期、生存月数、种族/民族和生存状况。进行多变量分析,以检查总体生存率,按诊断时年龄、诊断年份、手术接受风险和 12 个月内死亡风险的差异在不同种族/民族群体之间的差异。
与非西班牙裔白种女性(n=47475)相比,非西班牙裔黑人女性(n=4261)的总体死亡率风险增加(HR=1.28,CI:1.23-1.33),这在 50 岁以下诊断的女性中更为明显。与非西班牙裔白种女性相比,西班牙裔女性(n=7052)的生存率没有差异(HR=1.03,CI:0.99-1.07)。与非西班牙裔白种女性相比,非西班牙裔亚裔/太平洋岛民女性(n=5008)的风险略有降低(HR=0.95,CI:0.91-0.99)。与非西班牙裔白种女性相比,非西班牙裔黑人女性和西班牙裔女性接受手术干预的风险仍然很高。与非西班牙裔白种女性相比,非西班牙裔黑人女性、非西班牙裔亚裔/太平洋岛民女性和西班牙裔女性在癌症诊断后 12 个月内死亡的风险明显更高。
与非西班牙裔白种女性卵巢癌患者相比,不同种族/民族群体的生存差异仍然存在。应继续检查这些差异,努力缩小这些差距。